Confirmation of superiority of complete remission concept vs classical healing concept for treatment of patients with erosive GERD
- Registry ID
- EUCTR2006-000927-33
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE4
- Sponsor
- Nycomed GmbH
- Start date
- 2006-05-03
- Completion date
- 2007-10-11
- Last update
- 2026-08-16
Conditions
- gastroesophageal reflux disease
Summary
Evaluation of complete remission rates in patients with erosive GERD treated with pantoprazole 40 mg over 4/8/12/16 weeks and demonstration that patients in complete remission will have less endoscopic relapses and/or discontinue the study more seldom and have an increased quality of life compared to classically healed patients.
Locations
View on source registry